Skip to main navigation Skip to search Skip to main content

Characteristics of Type 1 Diabetes Among Patients Carrying the Protective HLA-DQB1*06:02 Allele

  • The Finnish Pediatric Diabetes Register
  • , Antti Mathias Taka
  • , Taina Härkönen
  • , Paula Vähäsalo
  • , Tommi Vatanen
  • , Johanna Lempainen
  • , Riitta Veijola
  • , Maaret Turtinen
  • , Jorma Ilonen
  • , Mikael Knip*
  • *Corresponding author for this work

Research output: Contribution to journalArticleScientificpeer-review

1 Citation (Scopus)
15 Downloads (Pure)

Abstract

We set out to examine in an observational study characteristics of type 1 diabetes at the time of diagnosis among paediatric patients carrying the protective HLA class II DQB1*06:02 allele. We compared characteristics of type 1 diabetes among 5530 Finnish children aged 0–14 years diagnosed between 2003 and 2018. Seventy-five children with type 1 diabetes carried the DQB1*06:02 allele. The carriers of DQB1*06:02 allele were compared to all children with type 1 diabetes without this allele and those with a high-risk genotype. We also analysed, how does the genotype of a high-risk haplotype paired with DQB1*06:02 affect the phenotype of patients with newly diagnosed type 1 diabetes. Carriers of the DQB1*06:02 allele were diagnosed at an older age than those with any other HLA class II genotype (p = 0.003) or the high-risk genotype (p < 0.001). After adjusting the results for age and sex, no significant differences in clinical markers were observed. Glutamic acid decarboxylase autoantibody (GADA) levels were higher among carriers of DQB1*06:02 when compared to those with other genotypes (p = 0.033). Having a high-risk haplotype paired with DQB1*06:02-positive haplotype was associated with higher levels of islet antigen 2 autoantibodies (IA-2A) (p < 0.001) and somewhat shorter duration of symptoms (p = 0.043). The association between the protective DQB1*06:02 allele and an older age at diagnosis as well as higher levels of GADA at diagnosis of type 1 diabetes was confirmed. The effects of the DQB1*06:02-positive haplotype seem to dominate when paired with a high-risk haplotype.

Original languageEnglish
Article numbere15720
Number of pages10
JournalHLA
Volume104
Issue number5
DOIs
Publication statusPublished - Nov 2024
Publication typeA1 Journal article-refereed

Funding

This work was supported by Medicinska underst\u00F6dsf\u00F6reningen Liv och H\u00E4lsa, Finska L\u00E4kares\u00E4llskapet and Pediatric Research Foundation in Finland. Funding: Funding: This work was supported by Medicinska underst\u00F6dsf\u00F6reningen Liv och H\u00E4lsa, Finska L\u00E4kares\u00E4llskapet and Pediatric Research Foundation in Finland. This work was supported by Medicinska underst\u00F6dsf\u00F6reningen Liv och H\u00E4lsa, Finska L\u00E4kares\u00E4llskapet and Pediatric Research Foundation in Finland. The authors thank all the participants, hospitals and personnel of the Finnish Pediatric Diabetes Register.

Funders
Medicinska Understödsföreningen Liv och Hälsa
Finska Läkaresällskapet and Pediatric Research Foundation in Finland
Finnish Pediatric Diabetes Register

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • autoantibodies
    • children
    • genetic risk
    • HLA genotype
    • type 1 diabetes

    Publication forum classification

    • Publication forum level 1

    ASJC Scopus subject areas

    • Immunology and Allergy
    • Immunology
    • Genetics
    • Pediatrics, Perinatology, and Child Health

    Fingerprint

    Dive into the research topics of 'Characteristics of Type 1 Diabetes Among Patients Carrying the Protective HLA-DQB1*06:02 Allele'. Together they form a unique fingerprint.

    Cite this